The significance of the specific Nusselt number on a variety of factor. حسب Siva Sankari (2827295)

الموضوعات:

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_NSAID use may decrease serum Klotho levels.docx حسب Jingchao Yan (14079168)

"…Subgroup analyses did not reveal any statistically significant interactions.</p>Conclusion<p>Contrary to previous speculations, the use of NSAIDs is associated with a decrease in serum Klotho levels.…"

Sensory-evoked potentials of N80 and N150. حسب Soheila Qanbari (20455173)

الموضوعات:

Compression index of improved red clay. حسب Quan Shen (37564)

الموضوعات:

Compressibility modulus of improved red clay. حسب Quan Shen (37564)

الموضوعات:

Compressive strain of improved red clay. حسب Quan Shen (37564)

الموضوعات:

General procedure for the synthesis of A and A-c1. حسب Xueqin lu (22250795)

الموضوعات:

Wear morphology: (a) UT, (b) SP1, (c) SP2, and (d) SP3. حسب Huashen Guan (20454677)

الموضوعات:

Residual stress of various samples: (a) surface residual stress and (b) residual stress in the depth direction. حسب Huashen Guan (20454677)

الموضوعات:

Difference in (a) IL-17, and (b) TNF-α relative gene expression levels between baseline and six months after treatment using systemic and local antibiotic treatment. حسب Iva Milinkovic (22331710)

الموضوعات:

Improvement effect of lactoferrin and Coenzyme Q10 on body composition of mice with sarcopenia. حسب Wenbin Wu (292223)

الموضوعات:

Microstructure of various samples: (a) UT, (b) SP1, (c) SP2, and (d) SP3. حسب Huashen Guan (20454677)

الموضوعات: